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Abstract
The prevalence of chronic diseases, both communicable and non communicable, has 
continued to increase worldwide and its consequences including psychiatric co-mor-
bidity with accompanying decrease in quality of life of the sufferers. The aim of this 
study, therefore, was to determine the quality of life of patients with HIV, Tuberculosis, 
Diabetes Mellitus and Hypertension and the effect of psychiatric comorbidity on the 
quality of life and well-being of these patients who attend the different out-patient clinics 
of the University of Port Harcourt Teaching Hospital( UPTH). Following ethical approval 
and informed consent from the participants, 120 subjects from each group of HIV, 
Tuberculosis, Diabetes Mellitus and Hypertension were recruited based on the study’s 
inclusion and exclusion criteria. Subjects were further administered with the study’s 
instruments including the socio-demographic/clinical questionnaire, GHQ-12, WHO 
Composite International Diagnostic Interview (WHO CIDI) and the WHO QOL-Bref. 
The data were analyzed using the Statistical Package for Social Sciences (SPSS)  version 
20 statistical package. Confidence interval was set at 95% while P- value of less than 0.05 
was considered statistically significant. The study found a prevalence of psychiatric co-
morbidity of 43.75% in all. Tuberculosis had the highest prevalence of psychiatric comor-
bidity with 63(52.5%), followed by . hypertension with 59(49.17%),  and Diabetes mellitus 
46 (38.3%), while HIV was the least with 42(35%).  There were significant relationships 
between the presence of psychiatric co-morbidity and  level of education(p=0.004), 
income class(p=0.001) in all four medical conditions and  self stigma for HIV and tuber-
culosis.  Hypertension had the highest average mean quality of life with 6.34+253 fol-
lowed by HIV with 60. , diabetes with 5.8 while tuberculosis had the least with mean 
quality of life 5.3(p=0.001). However, when quality of life was associated with psychiatric 
comorbidity, the mean quality of life was 5.9, 5.6, 5.2 and 4.9 for Hypertension, diabe-
tes, HIV and tuberculosis respectively. The management of patients with  these medical 
conditions should therefore necessarily  include adequate attention to the mental health 
status the sufferers. 
Keywords: Chronic medical diseases, Psychiatric Co-morbidity, QOL, Well-being, 
UPTH
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1. Introduction
The prevalence of chronic medical diseases, both communicable including HIV [1] and tubercu-
losis infections [2] and non-communicable including diabetes mellitus [3] and hypertension [4], 
has continued to increase worldwide with a corresponding increase in the awareness of their 
possible comorbidities. These four medical conditions are among the most common chronic 
conditions in Sub-Saharan Africa and indeed worldwide [3, 5]. Psychiatric comorbidities have 
been identified as one of the commonest groups of comorbidities associated with chronic medi-
cal conditions [6–8]. Knowledge of psychiatric comorbidities particularly in these four chronic 
medical conditions has increased tremendously over the past decades and their effects on 
chronic disease outcome particularly quality of life and well-being have remained a growing 
concern [9, 10]. Even in the presence of all these findings, there is still low level of awareness 
of the psychological effects of these medical diseases particularly among clinicians who are 
non-psychiatrists. This often leads to poor management of patients, high morbidity, mortality 
and poor prognostic outcome.
In 2010, it was reported that diabetes mellitus affected about 285 million adults (age 20–79 
years) worldwide and this figure may increase to about 439 million adults by 2030 [3]. 
Similarly, tuberculosis is reported as one of the leading causes of mortality worldwide [12], 
with the World Health Organization (WHO) estimation of about two billion people, having 
latent tuberculosis. This number of persons makes up almost a third of the world’s popu-
lation [5, 11]. Every year about eight million people develop this disease, and some three 
million die of it, with more than 95% of these from developing countries [13]. A study [14] 
estimates a prevalence of between 10 and 15% of adult populations worldwide to have high 
blood pressure which also agrees with similar report in Africa [15]. But this is different from 
other studies which reported a prevalence of 15–30% in adults worldwide [16]. Five key fac-
tors have been identified to be associated with hypertension in the Western world: increasing 
age, obesity, elevated pressure in blood relative, environment and race [17]. Furthermore, 
over 36 million people have contracted HIV infection worldwide and about 16 million people 
are said to have died from the disease [1, 7]. In the 1960s and 1970s, HIV-related disorders 
and AIDS were increasingly common but unrecognized, particularly in Africa and North 
America. In Nigeria, the following prevalence rates have been reported for the four medi-
cal conditions: about 10–15% for diabetes mellitus [4] and about 4.6% for HIV infection [1], 
10–15% for essential hypertension [14], and increasing from 11.2% in 1990 to 27.9% in 2010 in 
rural communities in the Niger Delta, and 44.3% in urban Lagos [18, 19] while tuberculosis 
is 36–45% [20].
Although these four medical conditions may appear dissimilar, within them lie some com-
parative similarities. Diabetes mellitus and hypertension have genetic component, adverse 
environmental factors, and prevalent life style as major risk factors [21–24], while HIV and 
tuberculosis are both chronic infectious diseases and are mainly acquired from infected 
objects or persons [25, 26]. In fact, a strong genetic association between diabetes mellitus and 
depression has been reported [27, 24]. Also, HIV and tuberculosis infections, unlike  diabetes 
and hypertension, are associated with high level of stigmatization and social  discrimination 
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[28, 29]. These diseases have similar complications which include among others diabetic 
 ketoacidosis, HIV and hypertensive encephalopathies, and CNS disseminated tuberculosis 
which may affect all the brain cells, leading to altered sensorium, neuro-affections, neuro-
deficits, cognitive impairment, organic mental syndrome and in some individuals seizures 
may occur. Similarly, all four illnesses could directly impair important neurotransmitter func-
tions due to their direct toxic effects on the brain cells (neurons) either from the viral cells 
[30] or other opportunistic infections [31], disseminated tuberculosis to the CNS, hypertensive 
encephalopathy or due to ketoacidotic complication. All these are capable of disrupting the 
neurotransmitter system and this may affect the limbic system, the center that regulates mood 
in humans.
2. Chronic medical conditions and psychiatric comorbidity
Chronic medical diseases, besides being associated with high rate of mortality, are equally 
associated with various forms of comorbidities and psychiatric comorbidity appears to be 
most common and most disabling [31–37]. It has been reported that about 20% of patients with 
somatic diseases suffer from major depression [38]. Strong causal associations have equally 
been found to exist between mental disorders especially depression, anxiety and hyperten-
sion and diabetes [39, 40]. Besides the genetic components, persistent environmental stress-
ors are also well-known triggers for hypertension and diabetes mellitus [23]. They  rearrange 
and over intensify the sympathetic system [42] by initiating or enhancing the release of nor-
epinephrine which stimulates the sympathetic pathway. Thus, this neurotransmitter is con-
sequently hyperactivated and becomes oversensitized in most chronic diseases. This causes 
both hypertension and anxiety disorders including panic disorder, General Anxiety Disorder 
(GAD), acute stress disorder and posttraumatic stress disorder (PTSD) [43–45]. Also, most of 
the psychotropic drugs have been known to be diabetogenic either by slowing down body 
metabolism including carbohydrates and or causing increased appetite. Again, a genetically 
causal link has been established between depression and diabetes with abnormal chromo-
some 21 being implicated. Additionally, the presence of anxiety alone could lead to hyperten-
sion and diabetes mellitus in predisposed individuals [39, 40].
Infectious chronic medical diseases like HIV and tuberculosis equally create multiple burdens 
for patients, including the need to deal with pain, suffering, reduced quality of life, poor 
compliance to medication, premature mortality, financial costs, stigma, discrimination, isola-
tion, rejection and familial emotional trauma [46]. The co-existence of psychiatric disorders 
with various communicable and non-communicable diseases (NCDs) is a relevant phenom-
enon, which tend to be chronic in nature and has significant implications in the patient’s 
well-being, quality of life, cost of treatment as well as longevity of the patient. Other avail-
able evidence have clearly showed an increasing prevalence of psychiatric comorbidities 
among communicable and NCD patients [32–34, 47, 48]. The chronic nature of these medical 
 illnesses, their persistent and recurrent symptoms, impairment in functioning capacity, as 
well as other adverse environmental psycho-social burdens and even the worried thought of 
these can also in turn cause anxiety and may also quickly drive the patient into depression, 
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suicidal ideation or attempt, and ultimately suicide. It is therefore important to note that the 
adverse environmental factors could lead to both the medical conditions and mental illness 
and can equally aggravate them. Although HIV- and tuberculosis-infected patients under 
anti-retroviral (arbacire and niverapine) and anti-tuberculosis drugs (isoniazid, ethambutol 
and cycloserine) therapy infrequently suffer acute organic psychotic complications [49–52], 
the chronicity of the disease places them at greater risk for psychiatric comorbidity than the 
general population [53]. Acute episodes of mania or manic phase of bipolar affective disorder 
tend to occur in HIV and tuberculosis patients [54, 55].
In addition to the effect of psychiatric comorbidity on quality of life in patients with chronic 
diseases, depression also contributes to poor self-care, reduced immunity, poor adher-
ence to medical treatment, higher rates of medical morbidity and mortality and increased 
health-care costs [56, 57]. The enduring thought of the prolong illness, and the tendency for 
long-term treatment including the inconvenience of routine or daily parenteral or oral medi-
cation, the functional incapacitation, the burden of care including financial, the stigma (both 
externalized and internalized) and the social rejection are more than enough psycho-social 
factors to impact mental ill health. In addition to these, the presence of depressive symp-
toms is also related to hypertensive and diabetes self-care, reflected by a worse adherence 
to medications, diet and exercise advice including reduction on alcohol use [58, 59]. The 
available studies suggest that psychiatric comorbidity particularly depression may indeed 
precede a decrease in quality of life among patients suffering from chronic medical illness 
[60]. However, the possibility of reversed causality, for example, that a reduced quality of 
life or physical function in individuals with chronic diseases preceding the development of 
depressive symptoms cannot be ruled out. Chronic diseases, psychiatric comorbidity par-
ticularly depression and anxiety and quality of life are closely related triad. The causality 
and time course and path of these relations remain largely unknown. There is therefore 
need for an integrated chronic disease care approach that addresses both the practical and 
emotional issues.
It is also worthy of note that while some medications that are used in the treatment of 
these medical conditions are associated with neuropsychiatric side effects like channel 
blockers and propranolol for hypertension, strong association has also been found between 
some medications used in the treatment of some mental disorders and diabetes mellitus 
(Selective Serotonin Reuptake Inhibitor (SSRI) and Olanzepine) and hypertension (TCA). 
Mental disorders can equally predispose individuals to hypertension or diabetes [39–41], 
and also to acquiring HIV and or tuberculosis due to poor sense of judgment, leading to 
sexual indiscretion and other risk bearing practices [61]. In addition, the mentally ill are 
often taken advantage off and subjected to sexual assaults, which is one of the major modes 
of transmission of HIV infection. Furthermore, some medications have been known to be 
immunosuppresants in their action and by so doing can increase the vulnerability of indi-
viduals to these infections. Additionally, use of alcohol and other drugs of abuse, which is 
common in most chronic diseases, makes them vulnerable to enter casual or coercive sexual 
relationship [62–64]. Mental disorders particularly depression can lower immunity thereby 
making the individuals vulnerable to these infectious diseases.
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3. Quality of life and well‐being in patients with chronic medical conditions
The terms ‘quality of life’ and, more specifically, ‘health-related quality of life’ refers to the 
physical, psychological and social domains of health, seen as distinct areas that are influenced 
by a person’s experiences, beliefs, expectations and perception [65, 66], (‘which is referred 
here collectively as perceptions of health’). The emphasis within the above definition is first, 
on the subjective nature of QOL and second, on the need to assess all those aspects of life 
 considered as having significant impact on QOL and well-being of any individual. Quality 
of life assessment is aimed at measuring changes in physical, functional, mental and social 
health of the individual and then the population in order to evaluate the human and financial 
cost and benefits of new programs and interventions [65, 66].
‘Quality of life’ is characterized by an individual’s awareness on his ability to function well, 
cope with his or her daily demands and be in good health socially, physically and mentally 
[67]. A self-reporting questionnaire which is reliable and has valid numbers can use to mea-
sure one’s quality of life. This questionnaire is categorized in three main groups: generic, 
disease and domain specifications [68]. The generic specification measures patients’ quality 
of life irrespective of the presence of any diseases. The disease specification deals with the 
consequences, cost and depth of a specific disease on the patients’ quality of life. While the 
final domain specified on certain domains in patients’ quality of life, for example, if there are 
any physical inabilities.
Quality of life therefore is affected in a complex way by the individual’s physical health, 
psychological state, as well as their sense of independence, level of social relationships, per-
sonal beliefs and their other relationships to salient features of their environment. Quality 
of life also consists of fulfilling needs, meeting of social expectations and assessing opportu-
nities by using abilities. Abilities are impaired by ill health and worse still chronic medical 
illnesses [68–70]. Quality of life can be altered by both the immediate and the long-term 
consequences of treatment especially the case of chronic illnesses [71–78]. Hence, the focus 
of medical practice has always been directed toward relieving physical symptoms of chronic 
medical diseases which often overlook the huge impact on the physical and psychological 
well-being, psychiatric comorbidity and the overall patient’s quality of life. This has often 
resulted in monumental adverse health outcomes [79–81]. Also, emphasis is usually on treat-
ing the basic abnormality and most times symptomatology of the disease leaving the indi-
viduals’ own views of their state of well-being.
Most chronic medical conditions weaken patients’ physical functioning and impair their qual-
ity of life [82, 83]. It has become important that tuberculosis and HIV control programs at 
public health clinics design strategies to improve the quality of health of tuberculosis and 
HIV separately or co-infected patients. Tuberculosis affected all predicted domains of QOL, 
including general health perceptions, somatic sensation, psychological health, spiritual well-
being, and physical, social and role functioning [74–76]. Social stigmatization, isolation, pill 
burden, long duration of therapy, sexual dysfunction, loss of income and fear are associated 
with chronic medical diseases and all affect patients’ QOL and well-being. Despite available 
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curative therapy, chronic diseases and their treatment still have significant short- and long-
term consequences on patients’ QOL [69, 73, 75].
Several factors are known to influence both depressive symptoms and quality of life, includ-
ing age, sex, marital status, educational level or income [77, 81]. These factors may confound 
the association between depressive symptoms and quality of life. Depressive symptoms in 
individuals with chronic medical diseases are associated with a worse quality of life [84–88]. 
Generic, disease specific, as well as domain specific quality of life are poorer in the presence 
of depressive symptoms [89]. In addition, there is evidence that depressive symptoms can 
predict the development of functional limitations in the future, suggesting a causal relation-
ship between depressive symptoms and functional disability [90].
4. Aim
The aim of this study, therefore, was to determine the quality of life of patients with 
chronic medical diseases: HIV, tuberculosis, diabetes mellitus and hypertension and the 
effect of psychiatric comorbidity on the quality of life and well-being of these patients who 
attend the different out-patient clinics of the University of Port Harcourt Teaching Hospital 
(UPTH).
5. Methodology
Following ethical approval and informed consent from the participants, 120 subjects from 
each group of HIV, tuberculosis, diabetes mellitus and hypertension were recruited based 
on the study’s inclusion and exclusion criteria. Patients with additional medical condi-
tion including having two of the four illnesses under consideration, severely ill patients, 
for example, with evident AIDS and multi-drug resistant tuberculosis were excluded. Age 
range of 10–70 years was a criterion. A pilot study was carried out. Subjects were further 
administered with the study’s instruments including the socio-demographic/clinical ques-
tionnaire, GHQ-12, WHO composite international diagnostic interview (WHO CIDI) and 
the WHOQOL-Bref. The data were analyzed using the SPSS version 20 statistical package. 
Confidence interval was set at 95% while P value of less than 0.05 was considered statisti-
cally significant.
5.1. WHO QOL‐Bref
The World Health Organization quality of life assessment instrument, short version 
(WHOQOL-Bref, used in this study) is a 26-item questionnaire that assesses how patients 
feel about their life [91, 92].The WHOQOL produces a quality of life profile with four domain 
scores and general health facet. The four domain scores and general health facet test an indi-
vidual’s perception of quality of life in each particular domain. Scores on domain 1 assess 
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physical health; domain 2 psychological health; domain 3 social relationship and domain 
4 assess individual’s perception of the environment. Domain scores are scaled in a positive 
direction (higher score denotes higher quality of life) [91, 92]. QOL represents the effect of 
an illness on a patient, as perceived by the patient, and yields complementary information 
to medical or epidemiological data, and it is often used as an outcomes measurement [93]. 
QOL has also been characterized as ‘the ultimate goal of all health interventions’.
5.2. The general health questionnaire (GHQ‐12)
It is a self-administered screening instrument, which was designed to detect short-term 
changes in mental health (anxiety, depression, somatic symptoms and social dysfunctions) 
and to screen for psychiatric morbidity [94–96]. It is aimed at distinguishing between psy-
chological ill health and well-being. It can detect disorders of less than two-week duration. 
It focuses on breaks in normal functioning and is concerned with a person’s inability to con-
tinue with normal healthy functions and the experience of new phenomena of a distressing 
nature.
6. Results
6.1. Psychiatry diagnosis
From the study, tuberculosis had the highest prevalence of psychiatric comorbidity with 63 
(52.5%), followed by hypertension with 59 (49.17%), and diabetes mellitus 46 (38.3%), while 
HIV was the least with 42 (35%). Depression was the most common psychiatric disorder 
among all the medical conditions with 11.67, 15.83, 9.16 and 15% among diabetes, hyperten-
sion, HIV and tuberculosis, respectively, followed by generalized anxiety disorder. In a total 
of 12 patients (5 among the HIV and 7 among the tuberculosis) had psychosis, 2 and 3 cases 
which occurred following commencement of anti-retroviral and anti-tuberculosis medica-
tions, respectively (see Table 1).
S/N Psychiatric 
morbidity total
Diabetes mellitus 
(%)
Hypertension (%) PLWHV (%) Tuberculosis (%)
n = 120 n = 120 n = 120 n = 120
1 Depressive 
disorders (with 
or without 
psychosis)
14 (11.67) 19 (15.83) 11 (9.16) 18 (15.0)
2 GAD 8 (6.06) 10 (8.33) 7 (5.83) 11 (9.16)
3 Sexual 
dysfunctions
2 (1.66) 5 (4.16) 2 (1.66) 2 (1.66)
4 Mixed anxiety 
and depressive 
disorders
6 (5.0) 8 (6.66) 4 (3.33) 7 (5.83)
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6.2. Socio‐demographic and clinical correlates of psychiatric morbidity
In all four medical conditions, there was no significant relationship between the presence of 
psychiatric comorbidity and age class (P = 0.350), gender (P = 0.22), level of education (P = 043), 
income class (P = 0.81) and occupation. Persons who were married were significantly more 
likely to have a psychiatric comorbidity (P < 0.001). Also, those who reacted with either ‘very 
sad’ or a ‘wish to die’ when they received the diagnosis of the medical conditions were more 
likely to have psychiatric comorbidity (P = 0.001). There was also no significant relationship 
between age of onset of illness (P = 0.60), duration of illness (P = 0.73), duration of treatment 
(P = 0.82) and self-stigma (P = 0.15) (see Table 2).
6.3. Association of psychiatric comorbidity with quality of life among patients with 
diabetes mellitus, hypertension, HIV and tuberculosis
On domains 1 and 4, PLWHIV who had psychiatric comorbidity had better performance on 
quality of life, followed by hypertension, diabetes mellitus while tuberculosis had the least in 
similar domains. Furthermore, PLWHIV free of psychopathology also scored higher on general 
health facet (GHF) than similar group among the other three medical conditions (see Table 3).
S/N Psychiatric 
morbidity total
Diabetes mellitus 
(%)
Hypertension (%) PLWHV (%) Tuberculosis (%)
n = 120 n = 120 n = 120 n = 120
5 Substance abuse 3 (2.5) 5 (4.16) 3 (2.5) 5 (5.83)
6 Adjustment 
disorder
2 (1.66) 1 (0.83) 2 (1.66) 1 (0.83)
7 PSTD 0 (0) 0 (0) 3 (2.5) 3 (2.5)
8 Panic without 
agoraphobia
0 (0) 0 (0) 1 (0.83) 1 (0.83)
9 Dysthymia 3 (2.5) 4 (3.33) 2 (1.66) 3 (2.5)
10 Phantom 
disorders
2 (1.66) 0 0 (0) 0 (0)
11 Social phobia 2 (1.66) 3 (2.5) 2 (1.66) 2 (1.66)
12 Somatization 4 (3.33) 3 (2.5) 3 (2.5) 5 (4.16)
13 Personality 
disorders
0 (0) 1 (0.83) 1 (0.83) 2 (1.66)
14 BAD 0 (0) 0 0 1 (0.83) 3 (2.5)
15 Nil (No 
psychiatric) 
illness)
74 (62.0) 61 (51.0) 78 (65.0) 57 (47.5)
Note: Percentages reflect proportions within each medical conditions.
Table 1. Psychiatric comorbidity among diabetes.
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Variable DM Hypertension HIV TB Statistical 
Analysis
Psychiatric 
diagnosis
No psychiatric 
diagnosis
Psychiatric 
diagnosis
No psychiatric 
diagnosis
Psychiatric 
diagnosis
No psychiatric 
diagnosis
Psychiatric 
diagnosis
No psychiatric 
diagnosis
Age
<20 2 (1.67%) 5 (4.17%) 0 (0) 0 (0%) 4 (3.33%) 3 (2.5%) 3 (2.5%) 1 (0.83%)
P = 0.35
20–29 4 (3.33%) 13 (10.83%) 5 (4.17%) 13 (10.83%) 8 (6.67%) 18 (15%) 8 (6.67%) 15 (12.5%)
30–39 5 (4.17%) 12 (10%) 9 (7.57%) 11 (9.12%) 13 (10.83%) 26 (21.67%) 19 (15.83%) 18 (15%)
40–49 11 (9.12%) 18 (15%) 18 (15%) 15 (12.5%) 9 (7.5%) 17 (14.17%) 17 (14.17%) 15 (12.5%)
50–59 16 (13.33%) 15 (12.5%) 13 (10.83%) 10 (8.33%) 5 (4.17%) 12 (10%) 9 (7.5%) 6 (5%)
>60 8 (6.67%) 10 (8.33%) 14 (11.67%) 12 (10%) 2 (1.67%) 1 (0.83%) 6 (5%) 2 (1.67%)
Sex
Male 1 (11.67%) 31 (25.83%) 18 (15%) 29 (24.12%) 16 (13.33%) 31 (25.83%) 29 (24.12%) 27 922.5%) P = 0.22
Female 32 (26.67%) 43 (35.83%) 41 (34.12%) 32 (26.67%) 26 (21.67%) 47 (39.12%) 34 (28.33%) 30 (25%)
Marital status
Married 21 (17.5%) 32 (26.67%) 23 (19.2%) 26 (21.67%) 15 (5.8%) 31 (25.8%) 25 20 (16.6%) P < 0.001
Single 13 (5%) 20 (9.16%) 21 (9.2%) 24 (10%) 18 (15%) 34 (28.3%) 22 (18%) 18 (15%)
Divorced 4 (3.33%) 8 (15%) 6 (5%) 4 (3.33%) 4 (3.33%) 6 (5%) 6 (5%) 7 (5.8%)
Separated 5 (4.17%) 10 (6.65%) 4 (3.3%) 3 (2.5%) 5(4.17%) 5 4.17%) 5 (4.17%) 5 (4.17%)
Widowed 10 (8.33%) 13 (10.8%) 15 (12.6%) 16 (13.3%) 1 (0.8%) 2 1.67%) 4 (3.33%) 7 (5.8%)
Education
None 5 (4.17%) 6 (5%) 7 (5.83%) 4 (3.33%) 5 (4.17%) 9 (7.5%) 8 (6.67%) 6 (5%) P = 0.43
Primary 11 (9.17%) 21 (17.5%) 20 (16.67%) 21 (17.5%) 12 (10%) 23 (19.2%) 21 (19.2%) 14 (11.07%)
Secondary 13 (10.83%) 19 (15.83%) 19 (15.83%) 20 (16.67%) 13 (10.08%) 21 (17.5%) 19 (15.8%) 16 (13.3%)
Tertiary 18 (15%) 27 (22.5%) 13 (10.83%) 16 (13.3%) 12 (10%) 26 (21.67%) 15 (5.8%) 2319 (2%)
W
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Variable DM Hypertension HIV TB Statistical 
Analysis
Psychiatric 
diagnosis
No psychiatric 
diagnosis
Psychiatric 
diagnosis
No psychiatric 
diagnosis
Psychiatric 
diagnosis
No psychiatric 
diagnosis
Psychiatric 
diagnosis
No psychiatric 
diagnosis
Average monthly income
Low 14 (11.67%) 15 (12.5%) 16 (13.3%) 17 (14.17%) 14 (11.67%) 20 (16.67%) 28 (23.3%) 21 (17.5%) P = 0.81
Average 22 (18.33%) 35 (29.2%) 30 (25%) 34 (28.3%) 20 (16.67%) 39 (32.5%) 27 (22.5%) 29 (24.17%)
High 10 (8.33%) 24 (20%) 12 (10%) 16 (13.3%) 8 (6.67%) 19 (15.8%) 8 (6.67%)
Reaction to diagnosis
Normal 12 (10%) 37 (30.83%) 14 (11.67%) 24 (20%) 4 (3.33%) 10 (8.3%) 3 (2.5%) 5 (4.17%) P < 0.001
Sad 23 (19.2%) 26 (21.67%) 23 (19.2%) 21 (17.50%) 11 (9.17%) 31 (25.83%) 23 (19.2%) 25 (20.83%)
Very sad 11 (9.17%) 12 (10%) 22 (18.33%) 16 (13.3%) 19 (15.83%) 28 (23.33%) 26 (21.67%) 25 (20.83%)
Wish to die 0 (0%) 0 (0%) 0 (0%) 0 (0%) 10 (8.3%) 9 (7.50%) 11 (9.17%) 2 (1.67%)
Occupation
Managers 1 (0.8%) 2 (1.67%) 1 (0.8%) 1 (0.83%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
P = 0.14
Professionals 1 (0.8%) 3 (2.5%) 1 (0.8%) 2 (1.67%) 1 (0.83%) 3 (2.5%) 0 (0%) 0 (0%)
Technicians 
and Associates 
professionals
3 (2.5%) 6 (5%) 2 (1.67%) 3 (2.50%) 3 (2.50%) 4 (3.33%) 1 (0.83%) 2 (1.67%)
Clerical support 
workers
5 (4.17%) 8 (6.67%) 5 (4.17%) 5 (4.18%) 5(4.18%) 9(7.50%) 4 (3.33%) 4 (3.33%)
Service and sales workers
Skilled 
agricultural 
forestry and 
fishery workers
7 (5.83%) 11 (9.17%) 7 (5.83%) 8 (6.67%) 6 (5%) 10 (8.3%) 5 (4.18%) 6 (5%)
Craft and related 
trade workers
7 (5.83%) 13 (10.8%) 12 (10%) 13 (10.83%) 5 (4.18%) 15 (12.50%) 11 (9.17%) 13 (10.83%)
W
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Variable DM Hypertension HIV TB Statistical 
Analysis
Psychiatric 
diagnosis
No psychiatric 
diagnosis
Psychiatric 
diagnosis
No psychiatric 
diagnosis
Psychiatric 
diagnosis
No psychiatric 
diagnosis
Psychiatric 
diagnosis
No psychiatric 
diagnosis
Plant and 
machine 
operators and 
assemblers
6 (5%) 10 (8.33%) 8 (6.67%) 11 (9.17%) 6 (5%) 9 (7.5%) 13 (10.83%) 12 (10.00%)
Elementary 
occupation
10 (8.33%) 13 (10.08%) 11 (9.17%) 12 (10%) 9(7.50%) 14 (11.67%) 18 (15.00%) 13 (10.83%)
Armed forces 
occupation
0 (0%) 0 (0%) 3 (2.5%) 2 (1.67%) 2 (1.67%) 4 (3.33%) 0 (0%) 0 (0%)
Unemployed 6 (5%) 8 (6.67%) 7 (5.83%) 4 (3.33%) 5(4.18%) 10 (8.33%) 11 (9.17%) 7 (5.8%)
Age of onset of disease
<20 4 (3.3%) 7 (5.83%) 0 (0%) 0 (0%) 7 (7.5%) 15 (12.5%) 9 (7.50%) 5 (4.17%)
P = 0.004
20–29 9 (7.5%) 13 (10.83%) 10 (8.3%) 11 (9.17%) 18 (15%) 30 (25%) 13 (10.83%) 12 (10.00%)
30–39 15 (12.5%) 20 (16.67%) 16 (13.3%) 16 (13.3%) 12 (10%) 23 (19.17%) 24 (20%) 19 (15.83%)
40–49 11 (9.17%) 24 (20%) 24 (20%) 24 (20%) 4 (3.3%) 12 (10%) 12 (10%) 15 (12.5%)
>50 7 (5.8%) 10 (8.3%) 9 (7.5%) 10 (8.3%) 1 (0.8%) 5 (4.16%) 5 (4.16%) 6 (5%)
Duration of illness
<5 years 13 (10.83%) 18 (15%) 20 (16.67%) 21 (17.5%) 16 (13.3%) 28 (23.3%) 20 (16.67%) 16.13 (3%)
P = 0.0026–19 years 22 (18.3%) 44 (36.67%) 27 (22.5%) 29 (24.17%) 15 (5–8%) 30 (25%) 27 (22.5%) 27 (22.5%)
>11 years 11 (9.17%) 12 (10%) 12 (10%) 11 (9.17%) 11 (9.16%) 10 (8.33%) 16 (13.3%) 14 (11.67%)
Stigma
Yes 2 (1.67%) 0 (0%) 0 (0%) 0 (0%) 35 (29.17%) 48 (40%) 49 (40.8%) 40 (33.3)
P = 0.002
No 44 (67%) 74 (61.67%) 59 (49.17%) 61 (50.8%) 7 (5.8%) 30 (25%) 14 (11.67%) 17 (14.17%)
Table 2. Socio-demographic variables and psychiatric comorbidity among patients with diabetes, hypertension, HIV and tuberculosis.
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Medical 
condition
Status of 
psychiatric 
comorbidity
Domains of quality of life
Domain 1 
(Physical)
Domain 2 
(Psychological)
Domain 
3 (Social 
Relationship)
Domain 4 
Environment)
GHF
DM All patients 51.97 ± 14.77 56.20 ± 22.19 57.51 + 26.13 52.01 + 16.91 48.34 + 22.44
Psychiatric 
comorbidity
45.98 + 13.064 56.60 + 24.914 48.06 + 26.114 44.95 + 14.831 47.98 + 21.896
No psychiatric 
comorbidity
60.46 ± 12.788 61.05 + 13.362 66.80 + 21.378 59.62 + 16.503 51.91 + 23.319
HPT All patients 50.97 + 14.671 54.20 + 22.186 54.51 + 26.13 50.01 + 16.91 49.34 + 22.44
Psychiatric 
comorbidity
45.98.+ 13.064 56.60 + 24.914 48.06 + 26.114 44.95 + 14.831 47.98 +21.896
No psychiatric 
comorbidity
60.46 + 12.788 61.05 + 13.362 66.80 + 21.378 59.62 + 16.503 51.91 + 23.319
HIV All patients 60.71 + 15.57 62.34 + 26.32 61.57 + 25.04 55.15 + 14.00 65.81 + 21.84
Psychiatric 
comorbidity
46.70 + 10.103 48.67 + 15.016 46.84 + 21.032 50.33 + 10.456 63.83 + 20.349
No psychiatric 
comorbidity
66.36 + 13.698 67.85 + 27.870 57.09 + 14.888 67.50 + 24.102 66.61 + 22.418
TB All patients 50.97 + 14.671 54.20 + 22.186 54.51 + 26.13 50.01 + 16.91 49.34 + 22.44
Psychiatric 
comorbidity
45.98 + 13.064 56.60 + 24.914 48.06 + 26.114 44.95 + 14.831 47.98 + 21.896
No psychiatric 
comorbidity
60.46 + 12.788 61.05 + 13.362 66.80 + 21.378 59..62 + 16.503 51.91 + 23.319
Statistical 
analysis
P = 0.001 P = 0.001 P = 0002 P = 0.004 P = 0.24
DM = diabetes mellitus, HPT = hypertension, HIV = human immunodeficiency virus, TB = tuberculosis, GHF = general 
health facet.
Table 3. Association of psychiatric comorbidity with quality of life among patients with diabetes mellitus, hypertension, 
HIV and tuberculosis.
7. Discussion
Young adults from 35 years and above predominated the diabetic mellitus, hypertension and 
the tuberculosis groups. This is in agreement with earlier studies [4, 14, 18, 19, 35, 97, 98]. 
Apart from the influence of genetic predisposition, diabetic mellitus and hypertension are 
largely diseases of lifestyles including unhealthy eating habits, alcohol intake and sedentary 
lifestyles, which would manifest most among adults [4, 14, 18, 19]. Similarly, tuberculosis is 
an infective disease and exposure to it may be more in adults who work in health-care facili-
ties, are mostly close care givers to already infected persons, and also in individuals whose 
immunity may have waned due to poor nutrition, alcohol use, stress and other emotional 
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illnesses, most times occasioned by the medical illness, as well as other infective diseases. 
HIV had the most of youngest population with age group as young as 10–19 years taking 
16%, while the peak age was 30–39 years. This is in line with earlier finding that HIV is more 
prevalent among young persons [25].
The prevalence of essential hypertension was noted to be increasing with age and was about 
twice higher in the age groups 40–49 and 50–59 and above, compared to age group of 30–39, 
and about six times higher compared with age group 20–29. This result is consistent with 
earlier studies which reported that about 4.3 million Nigerians above the age of 15 years are 
classified as being hypertensive [15]. Furthermore, the prevalence has been said to be related 
to age, particularly in females, with a substantial increase occurring after the age of 50 [15]. 
Africans usually seek medical attention mostly when illness has presented with disabling 
symptoms, and in most cases late, in spite of awareness of the diagnosis [99–101]. This is par-
ticularly more so for essential hypertension and diabetes mellitus. Voluntary testing which is 
a key aspect of the HIV prevention and control program is yet to achieve 100% success rate.
A preponderance of females was observed among all disease conditions, especially PLWHIV 
and hypertension which recorded more proportions of females compared to diabetes and 
tuberculosis. HIV is equally well-known to be commoner among females. Several reasons 
have been postulated for this observation. Females, by reason of their reproductive anatomy, 
have larger surface area for the transmission of the virus. It has also been reported that the 
sperm contains heavy viral concentrations per/ml compared to vaginal fluid. Unfortunately, 
cultural factors further heighten this adversity among the female gender. Although essen-
tial hypertension is more common in males, females may have been over-represented in this 
study due to two reasons. First, African females tend to have lower blood pressure than males 
early in life with a reversal of the trend after the age 45–50 years [15]. This may be due to 
hormonal changes associated with the preparation for or actual menopause occurring at this 
age, couple with the increasing family and domestic (stressors) responsibilities shouldered by 
females in this age group. Males predominated among those with psychiatric comorbidity in 
all medical conditions except among PLWHIV. The tendency and willingness for females to 
present early to care facility may equally translate to early understanding of the nature and 
extent of their illness, early reduction in symptomatology and early reduction of emotional 
burden, which may all impact better mental health, good quality of life and well-being.
Also from the study, it was found that more of each of the categories (married, separated and 
widowed) had more psychiatric comorbidity among the hypertensives and diabetes than their 
corresponding groups in PLWHIV and tuberculosis. A possible explanation could be that in 
hypertension and diabetes, marital difficulties, separation and even widowhood may serve 
as baseline psycho-social factors that may act either singly or in synergy with the  medical 
stressor to cause psychiatric comorbidity. The presence of these psycho-social stressors alone 
can equally predispose to hypertension and diabetes due mainly to stress. In PLWHIV and 
tuberculosis, however, they are likely to influence the outcome of the disease, so there is more 
likelihood of marital difficulty, separation and even divorce in the chronic infective diseases, 
adding to the medical stressor. Thus, in hypertension and diabetes, they are both causal and 
effectual while in HIV and tuberculosis infections, they are more of effects.
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Most of the subjects in this study had attained various levels of formal education especially 
secondary and tertiary. Perhaps the influence of westernization and urbanization in Rivers 
State, Niger Delta and Nigeria might have played an important role. Furthermore, the cosmo-
politan nature of Port Harcourt, domiciling majority of ethnic groups in Nigeria, with over 
50% of Nigeria’s oil and gas businesses, makes education a priority. A good number (39%) of 
the subjects with hypertension and diabetes had tertiary education. The fact that they were 
educated may have increased their chances of employment and possibly ability to seek qual-
ity health care and timely too [102]. It is equally important to note that perhaps the older 
you become, and probably with more education, the more your socio-economic and fam-
ily responsibilities, with their accompanying stressors. A number of studies have implicated 
environmental stressors as important aetiological factors in high blood pressure and diabetes 
mellitus, particularly in already genetically predisposed individuals [21–24]. Occupational 
environments in Nigeria had remained stressful due to lack of job security and poor wages, 
confronting countless demands from members of the family in a poverty ravaged economy 
such as ours. In all groups, the incidence of psychiatric comorbidity was lowest among those 
with tertiary education. Hence, education tended to have some protective influence on the 
psyche of patients [102]. Expectedly, those with higher level of education were more likely to 
secure better employment, earn better income and have better access to quality health care, 
hence better quality of life and well-being.
In this study, there was significantly reduced rate of stigma among patients with hypertension 
and diabetes mellitus. Expectedly, therefore, the negative effect of stigmatization was felt more 
among patients with the infective conditions. Several studies have reported high rate of stigma-
tization among PLWHIV and tuberculosis [28, 29, 46, 103]. Due to fear of stigmatization with 
its accompanying negative psychological impact on the individual [104], such as to experience 
a second psychological trauma, many people living with HIV rather choose to avoid disclosure 
of their seropositive status, to even close relative, while such concealment is difficult in tuber-
culosis because of the natural course and eventual symptomatology of the disease. They have 
learned to absorb their shock alone because of a possible rebound negative effects of disclosure.
Majority of the respondents reacted ‘sadly’ or ‘very sadly’ to the diagnosis of their medical 
conditions. Of particular note was among subjects with HIV and tuberculosis infections where 
those who reacted ‘very sadly’ and even with a ‘wish to die’ were significantly higher compared 
to subjects with essential hypertension and diabetes. Death wish is the forerunner of suicidal 
ideation that may ultimately end in suicide. Thus, it is not surprising that 4 and 2 cases of 
suicide attempt were seen among PLWHIV and tuberculosis, respectively. The possible expla-
nation to this is the degree of stigma and social rejection usually associated with the chronic 
infective conditions, mainly born out of ignorance and socio-cultural factors [103, 104]. From 
the results, initial reaction to the diagnosis of chronic medical conditions seems to assume some 
importance in this study with regards to psychiatric comorbidity. Also of note here is that more 
people reacted very emotionally to diagnosis of communicable diseases than the non-commu-
nicable diseases. This is expected considering the level of stigma, discrimination, social rejection 
and isolation, need for adjustment, lowered self-esteem, fear of spreading the illness to others, 
helplessness brought about by incapacitation, associated with the former. Theses ultimately 
generate enormous psychological trauma, increase morbidity and mortality [29, 56, 104].
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The study found a prevalence of psychiatric comorbidity of 43.75% in all. Tuberculosis had 
the highest prevalence of psychiatric comorbidity with 63 (52.5%), followed by hypertension 
with 59 (49.17%) and diabetes mellitus 46 (38.3%), while HIV was the least with 42 (35%). 
Although, previous studies found variable prevalence rates of 82.6 [105], 46 [106] and 5–30% 
[107] for HIV, 72 [108] and 46–47.2% [109] for tuberculosis, 35% for hypertension [15] and 
37–48% for diabetes [36, 37], the lower prevalence rates of psychiatric comorbidity found in 
some of the medical conditions in this study particularly for HIV could be a reflection of 
increased awareness, following concerted efforts and aggressive campaigns by both govern-
ment and voluntary organizations, more access to existing medical care, articulated interven-
tional measures by government, such as the anti-retroviral and anti-tuberculosis schemes, 
and sustained efforts aimed at reducing stigma and discrimination. Furthermore, variable 
rates reported by previous studies may be due to the setting as well as methodology of the 
various studies.
Depressive illness was the most common in all four medical conditions, followed by gener-
alized anxiety disorder. In a total of 17 patients (6 among the HIV and 11 among the tuber-
culosis) had psychosis which occurred following commencement of anti-retroviral and 
anti-tuberculosis medications, respectively.
For HIV, depressive illness was … and this figure is similar to the finding of Olisah of 14.2% 
in a study in Nigeria [110] and also consistent with several other studies which put the prev-
alence of depression (among PLWHIV) at 5–25 [111] and 10–40% [112]. Females recorded 
higher percentage of depressive illness in all medical conditions, consistent with the male to 
female ratio of 1:2 in depression [110, 111]. This might also be due to reasons earlier given for 
overall psychiatric disorders. Anxiety and depression are frequently and highly occurring 
mental disorders in patients with chronic medical diseases [110–112]. When depression and 
anxiety comorbid with chronic medical diseases, it leads to poor adherence to medication, 
which is an important barrier to global control of chronic disease particularly tuberculosis 
and HIV and increases the risk of morbidity and mortality [113–116].
The possible aetiological mechanisms of depression in all four illnesses have been explained 
from the biological (physical) as well as the psychological points of view. For HIV, the viral 
cells and even some opportunistic infections and ketoacidosis and glucose deposit in the 
cerebral cortex may either directly destroy the brain cells responsible for emotions in the 
limbic system or in both cases, cause direct affectation of the neurotransmitter system alter-
ing their release or uptake, and in effect causing depression. From the psychological point 
of view, the burden of the illness, the thought of almost life-time use of medications, fear of 
and uncertainty about the future, chronic sense of rejection and feeling of loss, possible loss 
of functional capability with reduced quality of life, associated stigma in the case of HIV, 
and chronic leg ulcer and possible amputation in cases of complicated diabetic foot ulcers, 
regimented lifestyle particularly food intake for diabetes and fear of impending death, are 
all depressogenic factors and may have had additive effects for depression. Several studies 
have also established similar lines of thought [113–116]. The threat to life and perceived loss 
or difficulty having a life partner may be responsible for the anxiety among the PLWHIV and 
tuberculosis. The predominant feeling of loss involves functional incapability, loss of job, 
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relationship and even difficulty to secure a life partner. Truly, these are both depressogenic 
and anxiogenic. Another reason for the frequent comorbidity is that there are commonly 
shared risk factors for the development of a variety of psychiatric and medical disorders 
including smoking and low socio-economic status [117, 118].
Depression, generalized anxiety disorder, somatization, posttraumatic stress disorder (PTSD), 
acute stress disorder, panic disorder, adjustment disorder, substance abuse, sexual disfunc-
tion, psychosis and bipolar affective disorder are the most common stress-related conditions 
of chronic medical disorders in this study [45, 50, 119–121]. HIV and tuberculosis, with all 
the psycho-social difficulties including stigma and social isolation, and associated economic 
burden due to its chronic nature with very little hope of long-term survival, could be weighed 
as catastrophic to many sufferers. Chronic medical conditions are commonly associated with 
stressful conditions like loss of losses and unemployment, prolonged difficulties and people 
at war front. It has been found that stress, which potentially causes anxiety, also increases the 
level of cortisol which in turn causes increased deposition of arterosclerotic deposits in the 
intima of blood vessels. These deposits gradually narrow the lumen of the vessels. This in 
turn increases arterial pressure, resulting in hypertension. Excessive cortisol predisposes to 
diabetes mellitus.
Dependence on alcohol and other drugs could be the response to anxiety and depression as 
many of the sufferers may use them to self-medicate these disabling psychological symp-
toms and disorders [62–64]. There is a bidirectional relationship between substance abuse and 
chronic diseases, that is, substance abuse particularly alcohol can cause hypertension while 
hypertension, on the other hand, can precipitate substance abuse due to frustration [91–93]. 
However, the true relationship still remains difficult to establish in this study. People with 
chronic medical condition tend to abuse substance mainly to self-medicate their depression 
or to abate the many anxiety or anxiety-like symptoms that characterized hypertension, hence 
the use of propranolol and diazepam which have anxiolytic effects.
It is important to note that the viral cells alone or acting together with opportunistic infections, 
disseminating tuberculosis to the CNS or most substances of abuse, particularly alcohol, can 
directly impair or damage brain cells. Thus, these will synergistically hasten the deterioration 
of the health of the individual, thereby negatively affecting his/her psychological well-being 
and quality of life. Second, interactions between substances of abuse, particular alcohol, and 
anti-retroviral and anti-tuberculosis medications have also been associated with poor drug 
adherence, as well as reduced effectiveness of medications, which may result in unbearable 
side effects, often contributing to poor drug adherence.
Majority of the patients in all medical conditions fared well on most domain 65, 66, 76, 122–124]. 
The possible reasons being their focus on physical strength (e.g. evident physical health, absence 
of symptoms, ability to work around, available family support and a strong religious belief) 
than on their weaknesses (e.g. social discrimination, difficulty in having intimate relationships 
and reduced job opportunity). On domains 1 and 4, PLWHIV who had psychiatric comorbidity 
had better performance on quality of life, followed by hypertension, diabetes mellitus while 
tuberculosis had the least in similar domains. Furthermore, PLWHIV free of psychopathology 
also scored higher on GHF than similar group among the other three medical conditions.
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It is true that the stress, depression and lack of adequate social support which often may 
 synergistically hasten the progression of HIV to AIDS, and by so doing, cause rapid dete-
rioration in their psychological well-being and quality of life. However, in this study, it 
appeared that the combined effects of Government intervention programs and education for 
the general public as well as the supportive involvement by significant family members may 
have helped to increase the level of social support, reduced economic burden of care and 
associated stress which ultimately reduced the prevalence and severity of depression and 
other psychiatric disorders. This often results in improved quality of life. At present, more 
concern and care are given to PLWHIV, unlike diabetic mellitus, hypertensive and tuber-
culosis patients, from both governmental and non-governmental organizations, other social 
groups as well as the family.
Some authors have opined that quality of life will be poor in the developing countries like 
Nigeria where factors of finances, social relationships, health and personal safety are con-
sidered to be poor [124, 125]. Chronic medical conditions have high impact on the econ-
omy and with consequent low quality of life of individuals. The results in this study are 
consistent with many studies elsewhere [35, 125]. All domains of quality of life in those 
whose illness was complicated with psychiatric disorders among the medical conditions 
were affected, significantly worse in domains 1–4, compared to those without psychiatric 
comorbidity. This finding varied a little from previous studies where all domains of QOL 
except domain 4 (environment) and health satisfaction were affected by psychiatric comor-
bidity [125]. The result of this study is also consistent with the finding of Oliseh in his study 
done in Nigeria in which depression was the most prevalent psychiatric comorbidity, found 
that 63.6% subjects with depression had poor overall QOL while only 11.3% of subjects 
with no depressive disorder had poor overall quality of life and asserted that this could be 
representative, as depression has been identified as the most prevalent psychiatric illness in 
PLWHIV/AIDS [64].
In the presence of psychiatric comorbidity, the quality of life in PLWHIV and tuberculosis 
patients was significantly affected, particularly on the psychological and social domains com-
pared with diabetes mellitus and hypertension. This suggests that the stigma and social rejec-
tion associated with the communicable disease may play a significant role in the development 
of psychological illness. This also implies that even though psychiatric comorbidity is equally 
common in the diabetes mellitus and hypertension and affecting quality of life generally, the 
presence of psychiatric comorbidity in PLWHIV and tuberculosis tended to have more severe 
negative impact on quality of life.
The presence of symptoms of tuberculosis, hypertension and diabetes mellitus alone appear 
to be more disabling than those in PLWHIV, bearing in mind that acute cases were excluded. 
Moderate to severe cases of diabetes mellitus, hypertension and tuberculosis cause more 
symptoms and they are more disabling. This may account for the better quality of life among 
PLWHIV on the physical domain and the lower quality of life scores on both the physical and 
environment domains among them compared with PLWHIV.
In this study, it was observed that socio-demographic and clinical characteristics of respon-
dents in all medical conditions had some significant relationships with quality of life. Factors 
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like increased age, marital status (married), later age of onset of illness, education, employ-
ment, average to high monthly income, shorter duration of illness, longer duration of treat-
ment and emotional stability positively affected both psychiatric comorbidity and quality of 
life in all the groups. These results are consistent with several studies [124]. These suggested 
that a good number of psycho-social and clinical factors affected the outcome of the medical 
conditions. The implication of this is that these factors have to be addressed in the holistic 
management of these and indeed other chronic medical conditions. 
The effect of gender was variable. Although, females were more affected in most of the psy-
chiatric illnesses which is consistent with existing literature, this did not translate into lower 
quality of life for females on most domains of quality of life. This suggests that psychiat-
ric comorbidity in females tended to have better prognosis compared with males. From the 
study, females performed better on the overall quality of life, domains 2–4, while males fared 
better on health satisfaction and domain 1. This might be due to their better health-seeking 
behavior. Second, the obvious fact that most of the psychiatric disorders found in this study 
are usually associated with better prognosis in females, might have contributed to their better 
quality of life.
8. Recommendations
1. Based on the findings of this study, that chronic medical conditions carry the risk of psychi-
atric comorbidity with consequent affectation of quality of life and well-being, it becomes 
imperative that renewed efforts by Government, aimed at both primary and secondary 
prevention, be intensified for these chronic medical conditions.
2. That the intervention of Government in terms of increasing awareness campaign as well 
as free anti-retroviral and anti-tuberculosis scheme of the federal government for PLWHIV 
and tuberculosis should be sustained and further extended to non-communicable diseases.
3. Attention of clinicians should be drawn to diagnosing early psychiatric complications of 
chronic medical diseases and adequate management instituted or referrals made.
9. Conclusion
From the study, presence of psychiatric comorbidity and other psycho-social factors also 
influence the outcome of these medical conditions and to some extent significantly deter-
mined the psychological well-being and QOL. On account of the above, advocacy for a formal 
integration of functional Liaison-psychiatric practice has become imperative in the manage-
ment of most chronic medical conditions for optimal benefits of patients and physicians, 
as early identification and prompt attention to the psychological components will, no doubt, 
go a long way in improving the clinical outcomes of the sufferers.
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Furthermore, efforts of both governmental and non-governmental organizations in the man-
agement of chronic health conditions, including communicable and non-communicable con-
ditions should have clear objectives backed by legislation and not on ad hoc basis, as this 
would guarantee its sustenance.
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